Skip to main content
. 2019;20(9):2859–2864. doi: 10.31557/APJCP.2019.20.9.2859

Table 2.

CYP2C19 Genotype and Eradication Rates

CYP2C19 genotype (N=100) 7-day plus probiotics (N=25) 7-day plus placebo
(N=25)
14-day plus probiotics (N=25) 14-day plus placebo
(N=25)
PM (N=13; 13%) 3 (66.67%) 3 (100%) 3 (100%) 4 (100%)
IM No. (N=50; 50%) 10 (90%) 11 (81.81%) 15 (93.33%) 14 (78.57%)
RM No. (N=37; 37%) 12 (58.33%) 11 (72.72%) 7 (100%) 7 (100%)

*number in parentheses are eradication rates